Skip to content

Observational Study of Blood Biomarkers for Early Diagnosis of Diabetes Mellitus and Its Complications

Observational Study of Blood Biomarkers for Early Diagnosis of Diabetes Mellitus and Its Complications

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108965
Enrollment
Unknown
Registered
2025-09-09
Start date
2025-09-12
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

Uncomplicated diabetes mellitus:NA
Prediabetes:NA
DM with renal complications:NA
DM with ophthalmic complications:NA

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diabetes mellitus group: Diagnosed according to internationally recognized criteria (e.g., World Health Organization [WHO] or American Diabetes Association [ADA]), including type 1 and type 2 diabetes mellitus, further subdivided into diabetic retinopathy, diabetic nephropathy, and uncomplicated diabetes mellitus. 2.Prediabetes group: HbA1c levels meeting internationally recognized prediabetes criteria (WHO or ADA). 3.Healthy controls: Participants without diabetes mellitus or prediabetes and who do not meet any exclusion criteria. 4.Age >=18 years. 5.Written informed consent obtained.

Exclusion criteria

Exclusion criteria: 1.Severe systemic diseases, such as advanced renal failure (eGFR <30 mL/min/1.73 m^2), other significant renal diseases, hepatic or cardiac failure, respiratory or central nervous system disorders, and malignancies. 2.Psychiatric disorders or severe cognitive impairment. 3.Ocular conditions other than diabetic retinopathy. 4.Acute inflammation or infection. 5.History of neurotoxicity due to medications or metabolic neurotoxicity related to renal impairment. 6.Pregnancy or lactation. 7.Participation in other studies potentially affecting follow-up schedules. 8.Other conditions deemed inappropriate by investigators.

Design outcomes

Primary

MeasureTime frame
Baseline target protein indicator value;

Countries

China

Contacts

Public ContactBiao Yan

Shanghai General Hospital

yanbiao1982@126.com+86 21 36126254

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026